Senior insider sale
Chief Financial Officer at TAYSHA GENE THERAPIES, INC. — senior position signals high conviction
$492.9K
104.47K shares
What this filing means
ALAM KAMRAN plans to sell 104.47K shares of TAYSHA GENE THERAPIES, INC. valued at approximately $492.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2026ACC: 0001793412-26-000010
Officer· Chief Financial Officer
Since Sep 2020
104.47K
Shares to sell
$492.9K
Approx. market value
1.66K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
RSU Award
Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.
2/3/2026
1.66KTotal acquired1.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2026 | RSU Award Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer. | 1.66K | — |
| Total | 1.66K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
23.85K
Market value
$109.9K
1/26/2026
—Completed
Units to sell
78.97K
Market value
$375.1K
1/23/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
1.66K
Market value
$7.8K
2/4/2026
Total
Units
104.47K
Value
$492.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/26/2026 | 23.85K | $109.9K | — | Completed |
1/23/2026 | 78.97K | $375.1K | — | Completed |
| Planned — Approximate Date | ||||
2/4/2026 | 1.66K | $7.8K | Nasdaq | Planned |
| Total | 104.47K | $492.9K | ||